Tech24 Deals Web Search

Search results

  1. Results from the Tech24 Deals Content Network
  2. Viking Therapeutics stock rises on positive Phase 1 weight ...

    www.aol.com/finance/viking-therapeutics-stock...

    Viking Therapeutics is gearing up to compete with market GLP-1 leaders Novo Nordisk and Eli Lilly. ... Anjalee Khemlani is the senior health reporter at Yahoo Finance, covering all things pharma ...

  3. Why Viking Therapeutics Stock Is Skyrocketing Today - AOL

    www.aol.com/finance/why-viking-therapeutics...

    Keith Speights, The Motley Fool. July 25, 2024 at 12:03 PM. Shares of Viking Therapeutics (NASDAQ: VKTX) were skyrocketing 32.3% as of 11:21 a.m. ET on Thursday. The big gain came after the ...

  4. Could Viking Therapeutics Become the Next Novo Nordisk? - AOL

    www.aol.com/finance/could-viking-therapeutics...

    The much-feted biotech Viking Therapeutics (NASDAQ: VKTX) is aiming for Novo Nordisk's (NYSE: NVO) cash cow, the market for weight loss drugs. If its ambitions are fulfilled, it has a shot at ...

  5. Is Viking Therapeutics a Millionaire-Maker Stock? - AOL

    www.aol.com/finance/viking-therapeutics...

    According to a forecast by Goldman Sachs Research, the global weight loss drug market may multiply by a factor of 16 to reach $100 billion by the end of the decade. Today, Eli Lilly and Novo ...

  6. Viking Therapeutics stock has wild week after weight-loss ...

    www.aol.com/finance/viking-therapeutics-stock...

    Viking Therapeutics is the center of attention after doubling estimated weight-loss rates in a recent drug trial. ... ," BTIG analyst Justin Zelin told Yahoo Finance Live. "So [Lilly] saw about a ...

  7. Is Viking Therapeutics the Best Biotech Stock for You? - AOL

    www.aol.com/finance/viking-therapeutics-best...

    Viking is one of the more promising among the many, many drugmakers trying to join the anti-obesity market and challenge Eli Lilly and Novo Nordisk (NYSE: NVO). The biotech does have another ...

  8. Why Wall Street is so impressed with Viking Therapeutics ...

    www.aol.com/finance/why-wall-street-impressed...

    Viking Therapeutics is the center of attention after doubling estimated weight loss rates in new drug trials. ... BTIG analyst Justin Zelin told Yahoo Finance. “So they saw about a 7% weight ...

  9. The Bull Case for Viking Therapeutics Just Got Even ... - AOL

    www.aol.com/bull-case-viking-therapeutics-just...

    Viking Therapeutics (NASDAQ: VKTX) just gave shareholders a few more reasons to be excited for the future. With its shares soaring by a stunning 34% on July 25 thanks to second-quarter earnings ...